Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

Cited by (1,000)

Items 701–800 of 1,000

1. Wading pools, fading memories—place navigation in transgenic mouse models of Alzheimer's disease
   Heikki Tanila · 2012 · Frontiers in Aging Neuroscience
2. TDP-43: A new player on the AD field?
   Katherine L. Youmans, Benjamin L. Wolozin · 2012 · Experimental Neurology
3. Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice
   Wei Zhang, Guo Junhong, Xiaoyuan Niu, Wang Jie, Wang Zhaojun, Wu Meina, Wei Yang, Jun Zhang, Jin‐Shun Qi · 2017 · BioMed Research International
4. APP transgenic mice: The effect of active and passive immunotherapy in cognitive tasks
   Stephan Röskam, Frauke Neff, Rainer K.W. Schwarting, Michael Bacher, Richard C. Dodel · 2009 · Neuroscience & Biobehavioral Reviews
5. BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer′s disease
   Hui Wang, Ju-fang Huang, Lan Li, Jia Luo, Dan Chen, Jianbin Tong, Leping Zeng, Yan-qun Cao, Jian Xiang, Xue-Gang Luo et al. · 2016 · Neural Regeneration Research
6. Molecular Lysine Tweezers Counteract Aberrant Protein Aggregation
   Inesa Hadrović, Philipp Rebmann, Frank‐Gerrit Klärner, Gal Bitan, Thomas H. Schrader · 2019 · Frontiers in Chemistry
7. Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice
   Karin E. Sandoval, David S. Umbaugh, Austin House, A. Michael Crider, KEN A. WITT · 2019 · Neurochemical Research
8. Early changes in synaptic and intrinsic properties of dentate gyrus granule cells in a mouse model of Alzheimer's disease neuropathology and atypical effects of the cholinergic antagonist atropine
   David Alcantara‐Gonzalez, Elissavet Chartampila, Chiara Criscuolo, Helen E. Scharfman · 2021 · Neurobiology of Disease
9. Spatial coding defects of hippocampal neural ensemble calcium activities in the triple-transgenic Alzheimer's disease mouse model
   Xiaoxiao Lin, Lujia Chen, David Baglietto‐Vargas, Parsa Kamalipour, Qiao Ye, Frank M. LaFerla, Douglas A. Nitz, Todd C. Holmes, Xiangmin Xu · 2021 · Neurobiology of Disease
10. Parkin prevents cortical atrophy and Aβ-induced alterations of brain metabolism: 13C NMR and magnetic resonance imaging studies in AD models
    Norah Khaled Algarzae, Michaeline L. Hebron, Matthew Miessau, Charbel Moussa · 2012 · Neuroscience
11. Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent
    Duncan Ryan, David J. Koss, Emanuele Porcu, H. Woodcock, L. Robinson, Bettina Platt, Gernot Riedel · 2013 · Cellular and Molecular Life Sciences
12. Design, Synthesis, and Structure–Activity Relationship ofN-Arylnaphthylamine Derivatives as Amyloid Aggregation Inhibitors
    Roberto Di Santo, Roberta Costi, Giuliana Cuzzucoli Crucitti, Luca Pescatori, Federica Rosi, Luigi Scipione, Diana Celona, Mario Vertechy, Orlando Ghirardi, Paola Piovesan et al. · 2012 · Journal of Medicinal Chemistry
13. AβPP Accumulation and/or Intraneuronal Amyloid-β Accumulation? The 3xTg-AD Mouse Model Revisited
    Wirths, Oliver, Dins, Annika, Bayer, Thomas A. · 2012 · Journal of Alzheimer s Disease
14. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice
    Kapadia, Minesh, Mian, M. Firoz, Michalski, Bernadeta, Azam, Amber B., Ma, Donglai, Salwierz, Patrick, Christopher, Adam, Rosa, Elyse, Zovkic, Iva B., Forsythe, Paul et al. · 2018 · Journal of Alzheimer's Disease
15. Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles
    Botond Penke, Anikó M. Tóth, István Földi, Mária Szűcs, Tamás Janáky · 2012 · Electrophoresis
16. Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices
    Izumi Nomura, Hajime Takechi, Nobuo Kato · 2012 · Journal of Neurophysiology
17. Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease
    Iván Manuel, Laura Lombardero, Frank M. LaFerla, Lydia Giménez‐Llort, Rafael Rodríguez‐Puertas · 2016 · Neuroscience
18. Glutamate receptor delocalization in postsynaptic membrane and reduced hippocampal synaptic plasticity in the early stage of Alzheimer’s disease
    Ning Li, Yang Li, Li-Juan Li, Ke Zhu, Yan Zheng, Xiaomin Wang · 2019 · Neural Regeneration Research
19. The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer’s Disease
    Joana Poejo, Jairo Salazar, Ana M. Mata, Carlos Gutiérrez‐Merino · 2021 · International Journal of Molecular Sciences
20. Microvascular degeneration occurs before plaque onset and progresses with age in 3xTg AD mice
    Dominic Dimitri Quintana, Yamini Anantula, Jorge Alberto Garcia, Elizabeth B. Engler-Chiurazzi, Saumyendra N. Sarkar, Deborah R. Corbin, Candice M. Brown, James W. Simpkins · 2021 · Neurobiology of Aging
21. Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer’s Disease
    Estíbaliz González de San Román, Alberto Llorente‐Ovejero, Jonatan Martínez‐Gardeazabal, Marta Moreno‐Rodríguez, Lydia Giménez‐Llort, Iván Manuel, Rafael Rodríguez‐Puertas · 2021 · International Journal of Molecular Sciences
22. Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer’s disease
    Lisa S. Robison, Olivia J. Gannon, Abigail E. Salinero, Charly Abi‐Ghanem, Richard D. Kelly, David A. Riccio, Febronia Morcos Mansour, Kristen L. Zuloaga · 2023 · Biology of Sex Differences
23. Evaluation of the amyloid beta-GFP fusion protein as a model of amyloid beta peptides-mediated aggregation: a study of DNAJB6 chaperone
    Rasha M. Hussein, R. Hashem, L. Rashed · 2015 · Frontiers in Molecular Neuroscience
24. Function and Redox State of Peritoneal Leukocytes as Preclinical and Prodromic Markers in a Longitudinal Study of Triple-Transgenic Mice for Alzheimer's Disease
    Ianire Maté, Julia Cruces, Lydia Giménez‐Llort, Mónica De la Fuente · 2014 · Journal of Alzheimer s Disease
25. Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein‐specific antibodies
    Corinna Höfling, Markus Morawski, Ulrike Zeitschel, Elisa Roncati Zanier, Katrin Moschke, Alperen Serdaroglu, Fabio Canneva, Stephan von Hörsten, Maria Grazia De Simoni, Gianluigi Forloni et al. · 2016 · Aging Cell
26. Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer’s Disease
    Alberto Llorente‐Ovejero, Iván Manuel, Laura Lombardero, Maria Teresa Giralt, Catherine A. Ledent, Lydia Giménez‐Llort, Rafael Rodríguez‐Puertas · 2018 · Journal of Alzheimer s Disease
27. Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-β Burden
    Gisela Esquerda-Canals, Alejandro R. Roda, Joaquı́n Martı́, Laia Montoliu‐Gaya, Geovanny Rivera-Hernández, Sandra Villegas · 2019 · Journal of Alzheimer s Disease
28. Phospholipid transfer protein (PLTP) deficiency accelerates memory dysfunction through altering amyloid precursor protein (APP) processing in a mouse model of Alzheimer's disease
    Yawei Tong, Yang Sun, Xiaosheng Tian, Ting Zhou, Hecheng Wang, Tao Zhang, Rui Zhan, Lei Zhao, Bolati Kuerban, Zhengqian Li et al. · 2015 · Human Molecular Genetics
29. Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
    Lieven Declercq, Rik R. Vandenberghe, Koen Van Laere, Alfons Verbruggen, Guy M Bormans · 2016 · Frontiers in Pharmacology
30. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease
    Chao Wei, Wei Zhang, Qiong Zhou, Chao Zhao, Ying Du, Qi Yan, Zhuyi Li, Jianting Miao · 2016 · Neurochemical Research
31. Ubisol-Q10, a Nanomicellar and Water-Dispersible Formulation of Coenzyme-Q10 as a Potential Treatment for Alzheimer’s and Parkinson’s Disease
    Darcy Wear, Caleb Vegh, Jagdeep K. Sandhu, Marianna Sikorska, Jerome S. Cohen, Siyaram Pandey · 2021 · Antioxidants
32. Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease
    Jayeeta Manna, Gary Leo Dunbar, Panchanan Maiti · 2021 · Antioxidants
33. Intranasal Paclitaxel Alters Alzheimer’s Disease Phenotypic Features in 3xTg-AD Mice
    Donna J. Cross, Bertrand R. Huber, Michael A. Silverman, Marcella M. Cline, Trevor B. Gill, Chloe G. Cross, David G. Cook, Satoshi Minoshima · 2021 · Journal of Alzheimer s Disease
34. Untitled work
    2011 · Europe PMC (PubMed Central)
35. Inflammation in Alzheimer’s disease
    Michael Thomas Heneka · 2006 · Clinical Neuroscience Research
36. Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer’s disease
    Haitao Yu, Dian Wang, Liangyu Zou, Zaijun Zhang, Hua Xu, Feiqi Zhu, Xiaohu Ren, Benhong Xu, Jianhui Yuan, Jianjun Liu et al. · 2018 · Archives of Toxicology
37. Galanin Protects Against Intracellular Amyloid Toxicity in Human Primary Neurons
    Jia Cui, Qiuyue Chen, Xiaojing Yue, Xuejun Jiang, George F. Gao, Long‐Chuan Yu, Yan Zhang · 2010 · Journal of Alzheimer s Disease
38. Short-term high fat diet impairs memory, exacerbates the neuroimmune response, and evokes synaptic degradation via a complement-dependent mechanism in a mouse model of Alzheimer’s disease
    Sabrina E. Mackey-Alfonso, Michael J. Butler, Ashton Taylor, Alberto R. Williams-Medina, Stephanie M. Muscat, Hongjun Fu, Ruth M. Barrientos · 2024 · Brain Behavior and Immunity
39. Protein Aggregation Diseases: Toxicity of Soluble Prefibrillar Aggregates and Their Clinical Significance
    Massimo Stefani · 2010 · Methods in molecular biology
40. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer’s-like mouse models
    Sathish Kumar, Cynthia Ann Lemere, Jochen Walter · 2020 · Acta Neuropathologica Communications
41. Animal Models of the Sporadic Form of Alzheimer's Disease: Focus on the Disease and Not Just the Lesions1
    Khalid Iqbal, Silvia Bolognin, Xiaochuan Wang, Gustavo Basurto‐Islas, Julie Blanchard, Yunn Chyn Tung · 2013 · Journal of Alzheimer s Disease
42. A sensitive colorimetric strategy for monitoring cerebral β-amyloid peptides in AD based on dual-functionalized gold nanoplasmonic particles
    Yanyan Yu, Lin Zhang, Xiaoyu Sun, Chenglin Li, Yu Qiu, Hao-peng Sun, Daoquan Tang, Yao‐Wu Liu, Xiaoxing Yin · 2015 · Chemical Communications
43. Increased Tau Phosphorylation and Tau Truncation, and Decreased Synaptophysin Levels in Mutant BRI2/Tau Transgenic Mice
    Holly J. Garringer, Jill R. Murrell, Neeraja Sammeta, Anita Gnezda, Bernardino Francesco Ghetti, Rubén Vidal · 2013 · PLoS ONE
44. Effect of chronic and acute low-frequency repetitive transcranial magnetic stimulation on spatial memory in rats.
    Wei Li, Yuye Yang, Qing Ye, Bo Yang, Zheng-Rong Wang · 2007 · Brain Research Bulletin
45. Experimentally induced diabetes worsens neuropathology, but not learning and memory, in middle aged 3xTg mice
    Emi Hayashi-Park, Bria N. Ozment, Chelsea M. Griffith, Haiying Zhang, Peter R. Patrylo, Gregory M. Rose · 2016 · Behavioural Brain Research
46. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice
    Evelin Lisete Schaeffer, Sérgio Catanozi, Mark J. West, Wagner F. Gattaz · 2016 · Annals of Anatomy - Anatomischer Anzeiger
47. Intraneuronal β-Amyloid Is a Major Risk Factor – Novel Evidence from the APP/PS1KI Mouse Model
    Thomas A. Bayer, Henning Breyhan, Kailai Duan, Jens Rettig, Oliver Wirths · 2008 · Neurodegenerative Diseases
48. Vaccination Strategies for Alzheimer???s Disease
    Adele Woodhouse, Tracey C. Dickson, James Clement Vickers · 2007 · Drugs & Aging
49. The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer’s Disease
    Arun Kumar Ghosh, Emilio L. Cárdenas, Heather L. Osswald · 2016 · Topics in medicinal chemistry
50. Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models
    Shuo Pang, Siyuan Li, Hanzeng Cheng, Zhuohui Luo, Xiaolong Qi, Feifei Guan, Wei Dong, Shan Gao, Ning Liu, Xiang Gao et al. · 2023 · Frontiers in Molecular Neuroscience
51. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer’s Disease
    Minsook Ye, Hwan‐Suck Chung, Yong Ho An, Su-Jin Lim, Won Choi, Abigail Yu, Jin Su Kim, Manho Kang, Seung‐Hun Cho, Insop Shim et al. · 2015 · Molecular Neurobiology
52. Endogenous β-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells
    Valentina Echeverrı́a, Adriana Ducatenzeiler, C.H. Chen, A. Claudio Cuello · 2005 · Neuroscience
53. Electrophysiological Characterization of Networks and Single Cells in the Hippocampal Region of a Transgenic Rat Model of Alzheimer’s Disease
    Ingrid Heggland, Pål Kvello, Menno P. Witter · 2019 · eNeuro
54. RAPGEF2 mediates oligomeric Aβ‐induced synaptic loss and cognitive dysfunction in the 3xTg‐AD mouse model of Alzheimer’s disease
    You‐Na Jang, Hochung Jang, Gyu Hyun Kim, Jeong‐Eun Noh, Keun‐A Chang, Kea Joo Lee · 2020 · Neuropathology and Applied Neurobiology
55. Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-β
    Meng-Lu Liu, Ming-Jie Liu, Yan-Fei Shen, Hoon Ryu, Hyeon‐Jin Kim, Kristina Klupsch, Julian Downward, Seong‐Tshool Hong · 2009 · Journal of Cell Science
56. Homing in on Intracellular Aβ?
    Todd Eliot Golde, Christopher Janus · 2005 · Neuron
57. Diffusion MRI detects early brain microstructure abnormalities in 2-month-old 3×Tg-AD mice
    Falangola, Maria Fatima, Nie, Xingju, Ward, Ralph, McKinnon, Emilie T., Dhiman, Siddhartha, Nietert, Paul J., Helpern, Joseph A., Jensen, Jens H. · 2020 · NMR in Biomedicine
58. Aging induces abnormal accumulation of Aβ in extracellular vesicle and/or intraluminal membrane vesicle-rich fractions in nonhuman primate brain
    Shingo Koinuma, Nobuhiro Shimozawa, Yasuhiro Yasutomi, Nobuyuki Kimura · 2021 · Neurobiology of Aging
59. Limiting RyR2 open time prevents Alzheimer's disease‐related deficits in the 3xTG‐AD mouse model
    Yajing Liu, Jinjing Yao, Zhenpeng Song, Wenting Guo, Bo Sun, Jinhong Wei, John Paul Estillore, Thomas George Back, S.R. Wayne Chen · 2021 · Journal of Neuroscience Research
60. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer’s Disease
    Jean‐Pascal Morin, Giovanni Cerón-Solano, Giovanna Velázquez-Campos, Gustavo Pacheco‐López, Federico Bermúdez‐Rattoni, Sofía Y. Díaz-Cintra · 2016 · Journal of Alzheimer s Disease
61. Age-Related Changes of the Neurovascular Unit in the Cerebral Cortex of Alzheimer Disease Mouse Models: A Neuroanatomical and Molecular Study
    Alessandro Giuliani, Sandra Sivilia, Vito Antonio Baldassarro, Marco Gusciglio, Luca Lorenzini, Michele Sannia, Laura Calzà, Luciana Giardino · 2019 · Journal of Neuropathology & Experimental Neurology
62. Dopamine and Aβ-Induced Stress Signaling and Decrements in Ca2+ Buffering In Primary Neonatal Hippocampal Cells Are Antagonized by Blueberry Extract
    James A. Joseph, Amanda N. Carey, Gregory J. Brewer, Francis C. Lau, D.R. Fisher · 2007 · Journal of Alzheimer s Disease
63. Identification of amyloid-beta 1–42 binding protein fragments by screening of a human brain cDNA library
    María Elena Munguía, Tzipe Govezensky, Rodrigo Martinez, Karen Manoutcharian, Goar Gevorkian · 2005 · Neuroscience Letters
64. Alzheimer’s Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail
    Yu‐Jen Chang, Hoang Linh Nguyen, Yao‐Hsiang Shih, Hui‐Ming Yu, Mai Suan Li, Yun‐Ru Chen · 2016 · ACS Chemical Neuroscience
65. Progressive excitability changes in the medial entorhinal cortex in the 3xTg mouse model of Alzheimer’s disease pathology
    Chen, Lingxuan, Christenson Wick, Zoé, Vetere, Lauren M., Vaughan, Nick, Jurkowski, Albert, Galas, Angelina, Diego, Keziah S., Philipsberg, Paul A., Soler, Ivan, Feng, Yu et al. · 2023 · The Journal of Neuroscience
66. Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
    Darlene A. Mitrano, Samuel Houle, Patrick Pearce, Ricardo M. Quintanilla, Blakely K Lockhart, Benjamin C. Genovese, Rachel Schendzielos, Emma E. Croushore, Ethan M. Dymond, James W. Bogenpohl et al. · 2021 · IBRO Neuroscience Reports
67. Maternal High Fat Diet Anticipates the AD-like Phenotype in 3xTg-AD Mice by Epigenetic Dysregulation of Aβ Metabolism
    Francesca Natale, Matteo Spinelli, Marco Rinaudo, Sara Cocco, Ida Nifo Sarrapochiello, Salvatore Fusco, Claudio Grassi · 2023 · Cells
68. Normative mice retinal thickness: 16-month longitudinal characterization of wild-type mice and changes in a model of Alzheimer's disease
    Ana Batista, Pedro Guimarães, João Martins, Paula Isabel Moreira, António Francisco Ambrósio, Miguel S. Castelo-Branco, Pedro Serranho, Rui Bernardes · 2023 · Frontiers in Aging Neuroscience
69. Protein restriction slows the development and progression of pathology in a mouse model of Alzheimer’s disease
    Reji Babygirija, Michelle M. Sonsalla, Jericha Mill, Isabella James, Jessica H. Han, Cara L. Green, Mariah F. Calubag, Gina Wade, Anna Tobon, John Michael et al. · 2024 · Nature Communications
70. Therapeutic Approaches of Leptin in Alzheimers Disease
    Eva Carro · 2009 · Recent Patents on CNS Drug Discovery
71. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition
    David Baglietto‐Vargas, Masashi Kitazawa, Elaine J. Le, Tatiana Estrada-Hernandez, Carlos J. Rodríguez‐Ortiz, Rodrigo Medeiros, Kim N. Green, Frank M. LaFerla · 2013 · Neurobiology of Disease
72. Genetic Mouse Models of Alzheimer′s Disease
    Yann S. Mineur, Declan M. McLoughlin, Wim E. Crusio, Frans Sluyter · 2005 · Neural Plasticity
73. Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model
    Jacob A. Irwin, Alev Erişir, Inchan Kwon · 2016 · Current Alzheimer Research
74. BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR
    Vishruti S. Makani, Yong-gil Jang, Kevin Christopher, Wesley Judy, Jacob M. Eckstein, Kenneth Hensley, Nicolas L. Chiaia, Dong-Shik Kim, Joshua C. Park · 2016 · PLoS ONE
75. The p38 mitogen activated protein kinase regulates β-amyloid protein internalization through the α7 nicotinic acetylcholine receptor in mouse brain
    Kaige Ma, Jia Lv, Weina Yang, Ke-Wei Chang, Xiaodan Hu, Lili Shi, Wan-Ying Zhai, Hang-Fan Zong, Yi‐Hua Qian · 2017 · Brain Research Bulletin
76. A new statistical method to analyze Morris Water Maze data using Dirichlet distribution
    Marianne Maugard, Cyrille Doux, Gilles Bonvento · 2019 · F1000Research
77. Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice
    Fei Wang, Xueyan Shen, Shuping Li, Long Chen, Yanru Wang, Jie Qin, Guomin Zhou, Yuwen Peng, Xiaoyuan Feng, Ruixi Li et al. · 2015 · Oncotarget
78. Coexisting Cholinergic and Parahippocampal Degeneration: A Key to Memory Loss in Dementia and a Challenge for Transgenic Models?
    Jean‐Christophe Cassel, Chantal Mathis, Mark J. Majchrzak, Pierre‐Henri Moreau, John C. Dalrymple‐Alford · 2008 · Neurodegenerative Diseases
79. Amyloid β and impairment in multiple memory systems in older transgenic APP TgCRND8 mice
    Hanna, A., Horne, P., Yager, D., Eckman, C., Eckman, E., Janus, C. · 2009 · Genes, Brain and Behavior
80. Development, Optimization and Use of Preclinical Behavioral Models to Maximize the Productivity of Drug Discovery for Alzheimer's Disease
    Mark D. Lindner, Robert Albert McArthur, Sam A. Deadwyler, Robert E. Hampson, Pierre N. Tariot · 2008 · Elsevier eBooks
81. Exercise and resveratrol increase fracture resistance in the 3xTg-AD mouse model of Alzheimer’s disease
    Mustafa F. Alkhouli, Jun Hung, Michaela Squire, Miranda Anderson, Monica J. Castro, Jeganathan Ramesh Babu, Layla Al‐Nakkash, Tom L. Broderick, Jeffrey H. Plochocki · 2019 · BMC Complementary and Alternative Medicine
82. IL-6 Trans-Signaling in the Brain Influences the Metabolic Phenotype of the 3xTg-AD Mouse Model of Alzheimer’s Disease
    Anna Escrig, Amalia Molinero, Brenda Berenice Pérez Méndez, Mercedes Giralt, Gemma Comes, Paula Sanchís, Olaya Fernández‐Gayol, Lydia Giménez‐Llort, Christoph Becker‐Pauly, Stefan Rose‐John et al. · 2020 · Cells
83. Frequency modulation of entorhinal cortex neuronal activity drives distinct frequency-dependent states of brain-wide dynamics
    Piergiorgio Salvan, Alberto Lazari, Diego Vidaurre, Francesca Mandino, Heidi Johansen‐Berg, Joanes Grandjean · 2021 · Cell Reports
84. Age-Related Oxidative Redox and Metabolic Changes Precede Intraneuronal Amyloid-β Accumulation and Plaque Deposition in a Transgenic Alzheimer’s Disease Mouse Model
    Crystal G. Pontrello, Joshua McWhirt, Charles G. Glabe, Gregory J. Brewer · 2022 · Journal of Alzheimer s Disease
85. Rational Design and Acoustic Assembly of Human Cerebral Cortex‐Like Microtissues from hiPSC‐Derived Neural Progenitors and Neurons
    Jibo Wang, Haowen Qiao, Zhenyan Wang, Wen Zhao, Tao Chen, Bin Li, Lili Zhu, Sihan Chen, Longjun Gu, Ying Wu et al. · 2023 · Advanced Materials
86. Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
    Miriam Bettinetti‐Luque, Laura Trujillo‐Estrada, Eduardo García‐Fuentes, Juana Andreo‐Lopez, Raquel Maria Sanchez-Varo, Lourdes Garrido‐Sánchez, Angela Gomez Mediavilla, Manuela G. López, Melissa García‐Caballero, Antonia Gutiérrez et al. · 2023 · British Journal of Pharmacology
87. Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer’s disease-associated proteopathology
    Ling Xie, Ryan N. Sheehy, Adil Muneer, Yan Xiong, John A. Wrobel, Feng Zhang, Kwang‐Su Park, Julia Velez, Jing Liu, Yan‐Jia Luo et al. · 2025 · Nature Communications
88. The combined treatment of amyloid-β1-42-stimulated bone marrow–derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice
    Fei Wang, Hanqiu Liu, Xueyan Shen, Hong Ao, Nick Moore, Lingling Gao, Long Chen, Heng Hu, Huiying Ma, Zixiao Yang et al. · 2014 · Neurobiology of Aging
89. Early active immunization with Aβ 3–10 -KLH vaccine reduces tau phosphorylation in the hippocampus and protects cognition of mice
    Yunpeng Cao, Jin-Chun Wang, Kun Zhu, Huiyi Zhang, Guoqing Wang, Huiying Liu · 2019 · Neural Regeneration Research
90. A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease
    Suchitil Rivera-Marrero, Alberto Bencomo-Martínez, Erika Orta Salazar, Marquiza Sablón-Carrazana, Laura García-Pupo, Florencia Zoppolo, Florencia Arredondo, Rosina Dapueto, María Daniela Santi, Ingrid Kreimerman et al. · 2020 · Bioorganic & Medicinal Chemistry
91. Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
    Thomas Gabriel Schreiner, Bogdan Ovidiu Popescu · 2022 · Life
92. Exogenous β-amyloid peptide interferes with GLUT4 localization in neurons
    Leandro Teixeira de Oliveira, Gabbriela Leon, David William Provance, Fernando Garcia De Mello, Martha Meriwether Sorenson, Verônica Pinto Salerno · 2015 · Brain Research
93. Immunization with Amyloid-β Attenuates Inclusion Body Myositis-Like Myopathology and Motor Impairment in a Transgenic Mouse Model
    Masashi Kitazawa, Vitaly Vasilevko, David H. Cribbs, Frank M. LaFerla · 2009 · Journal of Neuroscience
94. Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex
    Fani Koukouli, Marie Rooy, Uwe Maskos · 2016 · Aging
95. Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia
    Deepthi Yedlapudi, Liping Xu, Dan Luo, G. Marsh, Sokol V. Todi, Aloke K. Dutta · 2019 · Scientific Reports
96. Impairment of spatial memory consolidation in APP751SL mice results in cue-guided response
    Julie Blanchard, Guillaume Martel, Jean‐Louis Guillou, Xavier Noguès, Jacques Micheau · 2007 · Neurobiology of Aging
97. Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease
    Kun Jia, Jing Tian, Tienju Wang, Lan Guo, Zhenyu Xuan, Russell Howard Swerdlow, Heng Du · 2023 · JCI Insight
98. Using Drosophila amyloid toxicity models to study Alzheimer's disease
    Elli Tsintzas, Teresa Niccoli · 2024 · Annals of Human Genetics
99. Fecal Microbiota Transplantation ( FMT ) From a Human at Low Risk for Alzheimer's Disease Improves Short‐Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model
    Claire Chevalier, Benjamin B. Tournier, Moira Marizzoni, Rahel Park, Arthur Paquis, Kelly Ceyzériat, Aurélien M. Badina, Aurélien Lathuilière, Samantha Saleri, Floriana De Cillis et al. · 2025 · Genes Brain & Behavior
100. Accumulation and age-related elevation of amyloid-β within basal forebrain cholinergic neurons in the rhesus monkey
     Daphne Norvin, Garam Kım, Alaina Baker‐Nigh, Changiz Geula · 2015 · Neuroscience